MedPath

Rewarding Healthy Behaviors in Pregnancy and Postpartum

Not Applicable
Completed
Conditions
Pregnancy Related
Interventions
Behavioral: Aqueduct Contingency Management Platform
Registration Number
NCT05328622
Lead Sponsor
Transcendent International, LLC
Brief Summary

This is a single-arm pilot clinical trial with two primary research goals:

1. To test the efficacy of a software's ability to profile eligible individuals who decline participation in a clinical trial ("non-consenters") so that research staff may improve recruitment strategies for subsequent waves of potential participants.

2. To test the feasibility of using the software's contingency management program in a population of pregnant persons in their third trimester of pregnancy.

Detailed Description

The first aim of the study is to test the feasibility of using a software program to incentivize pregnant patients to adhere to their prescribed prenatal appointments, postnatal appointment, and healthy behaviors. Participants will receive daily text messages that encourage engagement with health behaviors, and then participants earn points when they attend their scheduled appointments, bring in prescribed monitoring logs, and take their medications as prescribed.

A related aim of the study is to examine the effectiveness of the software system in providing support to researchers in implementing targeted participant recruitment in a manner that is labor-efficient and sustainable. The study will determine the efficacy of the software for (1) using psycho-demographic data to achieve more representative enrollment vis-à-vis target populations and (2) iteratively tailoring outreach materials and communication techniques based on actionable insights about those who participate and those who decline to participate.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
27
Inclusion Criteria
  • Pregnant in third trimester of pregnancy
  • Between 18 and 52 years of age
  • Able to read and speak either English or Spanish
  • A patient at Mount Sinai Hospital's OB-Gyn Ambulatory E-Level Clinic
Exclusion Criteria
  • Not pregnant (or no longer pregnant)
  • Outside of age range
  • Unwilling or unable to complete surveys
  • Not a patient at the clinic of interest

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adherence Incentives ProgramAqueduct Contingency Management PlatformThe intervention administered to participants is an incentive program designed to motivate participants to attend to/adhere to their prescribed prenatal course of care via the Aqueduct platform.
Primary Outcome Measures
NameTimeMethod
Percentage of prenatal appointments attended4 months

Using data from Mt. Sinai's electronic medical record appointment tracking system, the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased attendance at scheduled prenatal visits compared with baseline data in the clinic about attendance rates.

Percentage of postpartum appointments attended4 months

Using data from Mt. Sinai's electronic medical record appointment tracking system, the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased attendance at scheduled postpartum visits compared with baseline data in the clinic about attendance rates.

Percentage of eligible target population who consent to participate4 months

Using descriptive statistics from recruitment, the investigators will determine whether the percentage (%) of eligible individuals from the population of pregnant women in their third trimester receiving prenatal care at the Mt. Sinai E-Level OB Clinic who elected to participate in the study increases between Wave 1 and Wave 2 of recruitment based upon changes in recruitment language.

Secondary Outcome Measures
NameTimeMethod
Changes in exercise habits between baseline and follow-up4 months

Using self-reported number of minutes of moderate intensity physical activity (measured as average minutes per week over the past month), the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased minutes of physical activity from baseline (start of third trimester) to follow-up (postpartum appointment \~6 weeks after giving birth).

Changes in healthy eating between baseline and follow-up4 months

Using self-reported frequency of eating fruits, vegetables, and fried foods (measured as average number of days per week over the past month), the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased frequency in consumption of fruits and vegetables, as well as decreased fried food consumption, from baseline (start of third trimester) to follow-up (postpartum appointment \~6 weeks after giving birth).

Changes in self-efficacy between baseline and follow-up4 months

Using the General Self-Efficacy questionnaire, the investigators will determine whether participants who received the Aqueduct system intervention demonstrate increased self-efficacy from baseline (start of third trimester) to follow-up (postpartum appointment \~6 weeks after giving birth). Respondents use a 5-point rating scale (1= strongly disagree; 3 = neither agree nor disagree; 5 = strongly agree). Total scores range from 8 - 40, with higher total scores indicating better/stronger self-efficacy. Instrument citation: Chen, G., Gully, S. M., \& Eden, D. (2001). Validation of a new general self-efficacy scale. Organizational Research Methods, 4(1), 62-83. Accessed via https://sparqtools.org/mobility-measure/new-general-self-efficacy-scale/#all-survey-questions

Trial Locations

Locations (1)

Mount Sinai Hospital OB-Gyn Clinic E-Level

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath